✦ LIBER ✦

Stueies on hepatic fibrogenesis (xxvi) activities of acid mucopolysaccharide sulfotransferases in chronic hepatic injury

✍ Scribed by Koizumi, T. ;Suematsu, T. ;Nakamura, N. ;Kawasaki, A. ;Furukawa, Y. ;Hiramatsu, K. ;Abe, H.

Publisher: Springer-Verlag
Year: 1970
Tongue: English
Weight: 82 KB
Volume: 5
Category: Article
ISSN: 0435-1339
DOI: 10.1007/bf02777857

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Studies on hepatic fibrogenesis (XVI) Qu

Studies on hepatic fibrogenesis (XVI) Qualitative changes of hepatic acid mucopolysac-charides in rats with experimental chronic hepatic damage

✍ Koizumi, T. ;Nakamura, N. ;Mukuda, T. ;Tamaki, A. ;Furukawa, Y. ;Abe, H. 📂 Article 📅 1967 🏛 Springer-Verlag 🌐 English ⚖ 133 KB

Clinical and experimental investigations

Clinical and experimental investigations of imuran in various liver injuries (1) studies on chronic active hepatitis

✍ Sakaue, S. ;Yamada, K. ;Okuyama, S. ;Masuko, K. ;Midorikawa, H. ;Ito, S. ;Takami 📂 Article 📅 1969 🏛 Springer-Verlag 🌐 English ⚖ 144 KB

Effects of ursodeoxycholic acid (UDCA) o

Effects of ursodeoxycholic acid (UDCA) on serum liver damage indices in patients with chronic active hepatitis

✍ E. Rolandi; R. Franceschini; A. Cataldi; V. Cicchetti; L. Carati; T. Barreca 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 347 KB

The effects of ursodeoxycholic acid (UDCA, 450 mg daily) in patients with histologically proven chronic active hepatitis (CAH) have been evaluated in a randomized, double-blind, placebo-controlled study. Twenty-six patients with serum alanine aminotransferase (ALT) values at least twice the normal u

Effects of ursodeoxycholic acid on serum

Effects of ursodeoxycholic acid on serum liver enzymes and bile acid metabolism in chronic active hepatitis: A dose-response study

✍ Dr. Andrea Crosignani; Pier Maria Battezzati; Kenneth D. R. Setchell; Maurizia C 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 579 KB

The effect of ursodeoxycholic acid administration on liver function tests and on bile acid metabolism was investigated in 18 patients with chronic active hepatitis. Three different doses of ursodeoxycholic acid-250 mg, 500 mg and 750 mg-were administered daily to each patient for consecutive 2-mo pe